Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson’s disease) – 2024 to 2029

SKU: GMS-1208

Format: PDF

Overall Rating
4.5/5

OVERVIEW

The global market for wearable injectors is projected to reach USD 10.3 billion by 2024, growing over the forecast period at a CAGR of 10.7%. The growth of this market is driven primarily by the increasing prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenarios in major markets, and developments in injector devices technology.

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 1

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 2

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 3

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 4

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 5

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 6

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 7

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 8

TABLE OF CONTENT

1 Global Wearable Injectors Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Wearable Injectors Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Wearable Injectors Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Wearable Injectors Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Wearable Injectors Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Wearable Injectors Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Wearable Injectors Market – By Type (Market Size – & million/billion)
8.1 On-body injectors
8.2 Off-body injectors

9 Global Wearable Injectors Market – By Therapy
9.1 Immuno-oncology
9.2 Diabetes
9.3 Cardiovascular Diseases
9.4 Other

10 Global Wearable Injectors Market – By Technology
10.1 Spring-Based
10.2 Motor Driven
10.3 Rotary Pump
10.4 Expanding Battery
10.5 Other

11 Global Wearable Injectors Market – By End-User
11.1 Hospitals
11.2 Clinics
11.3 Home Care Settings
11.4 Other

12 Global Wearable Injectors Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Wearable Injectors Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Wearable Injectors Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Amgen
14.3 Medtronic Plc
14.4 Insulet Corporation
14.5 Ypsomed
14.6 Becton, Dickinson And Company
14.7 Tandem Diabetes Care, Inc.
14.8 United Therapeutics Corporation
14.9 Valeritas, Inc.
14.10 Enable Injections
14.11 Steadymed Therapeutics
14.12 Company 11 & more

15 Global Wearable Injectors Market – Appendix
15.1 Sources
15.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00$5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The global market for wearable injectors is projected to reach USD 10.3 billion by 2024, growing over the forecast period at a CAGR of 10.7%. The growth of this market is driven primarily by the increasing prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenarios in major markets, and developments in injector devices technology.

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 9

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 10

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 11

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 12

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 13

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 14

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 15

Wearable Injectors Market by Type (On-Body and Off-Body injectors), Therapy (Cardiovascular diseases, Immuno-oncology, Diabetes, Thalassemia, Primary Immunodeficiency Disease, Parkinson's disease) - 2024 to 2029 16

TABLE OF CONTENT

1 Global Wearable Injectors Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Wearable Injectors Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Wearable Injectors Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Wearable Injectors Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Wearable Injectors Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Wearable Injectors Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Wearable Injectors Market – By Type (Market Size – & million/billion)
8.1 On-body injectors
8.2 Off-body injectors

9 Global Wearable Injectors Market – By Therapy
9.1 Immuno-oncology
9.2 Diabetes
9.3 Cardiovascular Diseases
9.4 Other

10 Global Wearable Injectors Market – By Technology
10.1 Spring-Based
10.2 Motor Driven
10.3 Rotary Pump
10.4 Expanding Battery
10.5 Other

11 Global Wearable Injectors Market – By End-User
11.1 Hospitals
11.2 Clinics
11.3 Home Care Settings
11.4 Other

12 Global Wearable Injectors Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Wearable Injectors Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Wearable Injectors Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Amgen
14.3 Medtronic Plc
14.4 Insulet Corporation
14.5 Ypsomed
14.6 Becton, Dickinson And Company
14.7 Tandem Diabetes Care, Inc.
14.8 United Therapeutics Corporation
14.9 Valeritas, Inc.
14.10 Enable Injections
14.11 Steadymed Therapeutics
14.12 Company 11 & more

15 Global Wearable Injectors Market – Appendix
15.1 Sources
15.2 Abbreviations

Download our eBook: Market Mastery

Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.

Related Research Reports